Global Fund: Declines in Malaria, HIV and TB Deaths Threatened by Donor Aid Cutbacks, Climate and Conflict 12/09/2025 Elaine Ruth Fletcher While deaths from malaria have fallen by 29% since over the past two decades, mortality could rise again this year due to the cuts in global health funding seen recently, says Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “There has been a significant impact…and I suspect that we […] Continue reading -> WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Global Immunization Rate Steady at 85% – but Coverage Gaps Propel Outbreaks of Measles and Other Diseases 15/07/2025 Elaine Ruth Fletcher The global childhood vaccination rate in 2024 held steady with 85% of infants and children receiving three doses of the vaccine for diphtheria, pertussis and tetanus (DPT), used as a global benchmark for immunization rates overall. However large, continued gaps in coverage are propelling outbreaks, including the highest rate of measles cases since 2019. “In […] Continue reading -> NIH-funded Human Trials Outside US Get Temporary Funding Reprieve 09/07/2025 Kerry Cullinan Human trials conducted outside the United States with funding from the US National Institutes of Health (NIH) halted by the Trump administration in May, may be permitted to continue. On 1 May, the NIH outlawed US researchers from making subawards to foreign research partners, jeopardising billions of dollars of research throughout the world. As a […] Continue reading -> Ghana’s FDA Head Appointed to Run African Medicines Agency 05/06/2025 Kerry Cullinan CEO of Ghana’s Food and Drugs Authority (FDA) Dr Delese Mimi Darko has been appointed the inaugural Director-General of the African Medicines Agency (AMA) by the agency’s Conference of State Parties (CoSP) at a meeting in Rwanda this week. Darko has a “wealth of experience and a distinguished track record in regulatory excellence”, according to […] Continue reading -> WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Includes Popular Anti-Obesity Drugs on Essential Medicines List for Diabetes Control 05/09/2025 Elaine Ruth Fletcher WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy – semaglutide or other comparable GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide. These drugs, as well as new PD-1/PD-L1 […] Continue reading -> WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Global Immunization Rate Steady at 85% – but Coverage Gaps Propel Outbreaks of Measles and Other Diseases 15/07/2025 Elaine Ruth Fletcher The global childhood vaccination rate in 2024 held steady with 85% of infants and children receiving three doses of the vaccine for diphtheria, pertussis and tetanus (DPT), used as a global benchmark for immunization rates overall. However large, continued gaps in coverage are propelling outbreaks, including the highest rate of measles cases since 2019. “In […] Continue reading -> NIH-funded Human Trials Outside US Get Temporary Funding Reprieve 09/07/2025 Kerry Cullinan Human trials conducted outside the United States with funding from the US National Institutes of Health (NIH) halted by the Trump administration in May, may be permitted to continue. On 1 May, the NIH outlawed US researchers from making subawards to foreign research partners, jeopardising billions of dollars of research throughout the world. As a […] Continue reading -> Ghana’s FDA Head Appointed to Run African Medicines Agency 05/06/2025 Kerry Cullinan CEO of Ghana’s Food and Drugs Authority (FDA) Dr Delese Mimi Darko has been appointed the inaugural Director-General of the African Medicines Agency (AMA) by the agency’s Conference of State Parties (CoSP) at a meeting in Rwanda this week. Darko has a “wealth of experience and a distinguished track record in regulatory excellence”, according to […] Continue reading -> WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Awards Top-Level Recognition to Regulatory Authorities in Canada, UK and Japan 08/08/2025 Editorial team The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading -> Global Immunization Rate Steady at 85% – but Coverage Gaps Propel Outbreaks of Measles and Other Diseases 15/07/2025 Elaine Ruth Fletcher The global childhood vaccination rate in 2024 held steady with 85% of infants and children receiving three doses of the vaccine for diphtheria, pertussis and tetanus (DPT), used as a global benchmark for immunization rates overall. However large, continued gaps in coverage are propelling outbreaks, including the highest rate of measles cases since 2019. “In […] Continue reading -> NIH-funded Human Trials Outside US Get Temporary Funding Reprieve 09/07/2025 Kerry Cullinan Human trials conducted outside the United States with funding from the US National Institutes of Health (NIH) halted by the Trump administration in May, may be permitted to continue. On 1 May, the NIH outlawed US researchers from making subawards to foreign research partners, jeopardising billions of dollars of research throughout the world. As a […] Continue reading -> Ghana’s FDA Head Appointed to Run African Medicines Agency 05/06/2025 Kerry Cullinan CEO of Ghana’s Food and Drugs Authority (FDA) Dr Delese Mimi Darko has been appointed the inaugural Director-General of the African Medicines Agency (AMA) by the agency’s Conference of State Parties (CoSP) at a meeting in Rwanda this week. Darko has a “wealth of experience and a distinguished track record in regulatory excellence”, according to […] Continue reading -> WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Immunization Rate Steady at 85% – but Coverage Gaps Propel Outbreaks of Measles and Other Diseases 15/07/2025 Elaine Ruth Fletcher The global childhood vaccination rate in 2024 held steady with 85% of infants and children receiving three doses of the vaccine for diphtheria, pertussis and tetanus (DPT), used as a global benchmark for immunization rates overall. However large, continued gaps in coverage are propelling outbreaks, including the highest rate of measles cases since 2019. “In […] Continue reading -> NIH-funded Human Trials Outside US Get Temporary Funding Reprieve 09/07/2025 Kerry Cullinan Human trials conducted outside the United States with funding from the US National Institutes of Health (NIH) halted by the Trump administration in May, may be permitted to continue. On 1 May, the NIH outlawed US researchers from making subawards to foreign research partners, jeopardising billions of dollars of research throughout the world. As a […] Continue reading -> Ghana’s FDA Head Appointed to Run African Medicines Agency 05/06/2025 Kerry Cullinan CEO of Ghana’s Food and Drugs Authority (FDA) Dr Delese Mimi Darko has been appointed the inaugural Director-General of the African Medicines Agency (AMA) by the agency’s Conference of State Parties (CoSP) at a meeting in Rwanda this week. Darko has a “wealth of experience and a distinguished track record in regulatory excellence”, according to […] Continue reading -> WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NIH-funded Human Trials Outside US Get Temporary Funding Reprieve 09/07/2025 Kerry Cullinan Human trials conducted outside the United States with funding from the US National Institutes of Health (NIH) halted by the Trump administration in May, may be permitted to continue. On 1 May, the NIH outlawed US researchers from making subawards to foreign research partners, jeopardising billions of dollars of research throughout the world. As a […] Continue reading -> Ghana’s FDA Head Appointed to Run African Medicines Agency 05/06/2025 Kerry Cullinan CEO of Ghana’s Food and Drugs Authority (FDA) Dr Delese Mimi Darko has been appointed the inaugural Director-General of the African Medicines Agency (AMA) by the agency’s Conference of State Parties (CoSP) at a meeting in Rwanda this week. Darko has a “wealth of experience and a distinguished track record in regulatory excellence”, according to […] Continue reading -> WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ghana’s FDA Head Appointed to Run African Medicines Agency 05/06/2025 Kerry Cullinan CEO of Ghana’s Food and Drugs Authority (FDA) Dr Delese Mimi Darko has been appointed the inaugural Director-General of the African Medicines Agency (AMA) by the agency’s Conference of State Parties (CoSP) at a meeting in Rwanda this week. Darko has a “wealth of experience and a distinguished track record in regulatory excellence”, according to […] Continue reading -> WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Delays Falsified Medicine Mechanism Reform Amid Health Crisis 27/05/2025 Maayan Hoffman & Stefan Anderson GENEVA, Switzerland — One in 10 medicines in low- and middle-income countries are substandard or falsified, a pervasive health crisis the World Health Organization (WHO) estimates kills over one million people globally each year. As the cost in millions of lives and billions of public health dollars from falsified medicines rises, member states at the […] Continue reading -> Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Patients, European and Indian Drug Companies Will Suffer Most from Trump Tariffs on Pharmaceuticals 09/04/2025 Kerry Cullinan Patients will face costlier medicine and European and Indian drug companies face billion-dollar losses if US President Donald Trump’s threat issued late Tuesday of “a major tariff on pharmaceuticals” produced outside his country is realised. However, amid chaos on the financial markets, Trump back-pedalled on Wednesday and announced a 90-day pause on all tariffs except […] Continue reading -> Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Marburg Outbreak Ends in Tanzania, but Africa Faces a Rising Tide of Health Crises 13/03/2025 Paul Adepoju Tanzania has extinguished a deadly outbreak of Marburg virus, but elsewhere across Africa, an alarming surge of health crises continue to unfold – including expanding mpox infections in Uganda, a cholera outbreak in Angola and a first-ever cholera case in neighbouring Namibia. The Marburg virus outbreak in Tanzania has officially ended, Tanzanian health authorities declared […] Continue reading -> Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing 14/02/2025 Paul Adepoju In a breakthrough moment for Africa’s vaccine independence, two landmark deals could help put the continent on a path to becoming a producer, not just a buyer, of life-saving vaccines. For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate […] Continue reading -> Posts navigation Older posts